Hemoperitoneum caused by spontaneous rupture of hepatocellular carcinoma in noncirrhotic liver. A case report and systematic review.
hemoperitoneum
hepatocellular carcinoma
noncirrhotic liver
staged hepatectomy
transcatheter arterial embolization
Journal
Open medicine (Warsaw, Poland)
ISSN: 2391-5463
Titre abrégé: Open Med (Wars)
Pays: Poland
ID NLM: 101672167
Informations de publication
Date de publication:
2020
2020
Historique:
received:
07
01
2020
revised:
23
04
2020
accepted:
01
06
2020
entrez:
18
12
2020
pubmed:
19
12
2020
medline:
19
12
2020
Statut:
epublish
Résumé
Hepatocellular carcinoma (HCC) is the sixth most common cancer. Spontaneous rupture of HCC is an acute complication with a high mortality rate. The HCC principally arises in the background of chronic liver disease and cirrhosis of the liver. In the last few years, the rising incidence of HCC in noncirrhotic liver suggests the presence of other factors that may play a role in liver carcinogenesis. We reviewed all cases treated at the University Surgical Department of Ospedali Riuniti of Foggia from 2009 to 2018. Only a single case of hemoperitoneum caused by spontaneous rupture of HCC in noncirrhotic liver was found. An extensive search of the relevant literature was carried out using MEDLINE, and a total of 58 published studies were screened from the sources listed. The management of this devastating emergency should be carefully analyzed, with stabilization of vital signs as soon as possible. Patient with ruptured HCC and hemoperitoneum without a prior history of cirrhosis and viral infections benefited from the role of transcatheter arterial embolization (TAE) as the preliminary treatment in order to have a more precise diagnosis and an optimal stabilization of the patient. Delayed or staged hepatectomy after TAE represents the definitive treatment.
Identifiants
pubmed: 33336031
doi: 10.1515/med-2020-0202
pii: med-2020-0202
pmc: PMC7712383
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
739-744Informations de copyright
© 2020 Nicola Tartaglia et al., published by De Gruyter.
Déclaration de conflit d'intérêts
Conflict of interest: The authors declare that they have no competing interests.
Références
J Gastrointest Surg. 2006 Mar;10(3):379-86
pubmed: 16504883
World J Gastroenterol. 2010 Mar 14;16(10):1221-5
pubmed: 20222165
World J Hepatol. 2010 Jan 27;2(1):49-51
pubmed: 21160956
Chirurgie. 1999 Dec;124(6):618-25
pubmed: 10676022
ANZ J Surg. 2006 Jun;76(6):448-52
pubmed: 16768766
HPB (Oxford). 2012 Jun;14(6):382-9
pubmed: 22568414
Int J Cancer. 2010 Dec 15;127(12):2893-917
pubmed: 21351269
Gastroenterology. 2009 Nov;137(5):1698-705
pubmed: 19664629
Int Med Case Rep J. 2015 Aug 17;8:165-7
pubmed: 26316825
Eur J Surg Oncol. 2000 Dec;26(8):770-2
pubmed: 11087643
World J Emerg Surg. 2012 Sep 21;7(1):30
pubmed: 22995633
Am J Surg Pathol. 2011 Sep;35(9):1356-63
pubmed: 21836491
Minerva Chir. 2002 Jun;57(3):347-56
pubmed: 12029230
Arch Surg. 2006 Feb;141(2):191-8
pubmed: 16490898
BMC Gastroenterol. 2009 Apr 30;9:29
pubmed: 19405938
Ann Ital Chir. 2014 Sep-Oct;85(5):431-7
pubmed: 25601366
Clin Radiol. 1998 May;53(5):338-41
pubmed: 9630270
J Surg Oncol. 1989 Jul;41(3):183-6
pubmed: 2545975
Urol Int. 2018;101(2):125-131
pubmed: 29055945
Surg Today. 1999;29(5):453-7
pubmed: 10333419
J Hepatobiliary Pancreat Surg. 2009;16(4):508-12
pubmed: 19381430
Pak J Med Sci. 2014 May;30(3):472-6
pubmed: 24948961
Ann Ital Chir. 2017 Nov 20;6:
pubmed: 29176078
Open Med (Wars). 2016 Nov 13;11(1):429-432
pubmed: 28352832
Ann Ital Chir. 2016;87:242-6
pubmed: 27345193
Gastroenterology. 2007 Jun;132(7):2557-76
pubmed: 17570226
Ann Ital Chir. 2013 Jul-Aug;84(4):405-10
pubmed: 23917151
Ann Ital Chir. 2016 Dec 20;5:
pubmed: 28003568
Surgery. 1998 Sep;124(3):526-35
pubmed: 9736905
Dig Surg. 2002;19(2):109-13
pubmed: 11978996
Nat Rev Gastroenterol Hepatol. 2013 Nov;10(11):656-65
pubmed: 24080776
AJR Am J Roentgenol. 2008 Dec;191(6):W231-9
pubmed: 19020209
J Clin Oncol. 2001 Sep 1;19(17):3725-32
pubmed: 11533094